Some of the key supporting evidence comes from studies of unconventional forms of epidermolysis bullosa simplex (EBS) and other disorders resulting from KRT5 or KRT14 mutations [77,78]. This evidence concerns the gene KRT5 and epidermolysis bullosa simplex.